Quick answer
Can you take Ozempic with Insulin Glargine (Lantus)? Major interaction — avoid combination if possible, or use under close clinical monitoring. Mechanism: Concomitant use of semaglutide with basal insulin produces additive glucose-lowering effects, materially increasing the risk of hypoglycemia. The risk is dose-dependent and most pronounced during semaglutide titration when insulin doses hav…
- Severity
- major
- Interaction type
- pharmacodynamic
- Monitoring focus
- More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
Always confirm with your prescriber. This is educational and based on FDA label data.
Key takeaways
- • Severity: Major — avoid or close monitoring.
- • Ozempic (type 2 diabetes (FDA-approved T2D)) and Insulin Glargine (Lantus) (Long-acting basal insulin (diabetes)).
- • Clinical management: Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber.
- • Monitoring: More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
Mechanism
Concomitant use of semaglutide with basal insulin produces additive glucose-lowering effects, materially increasing the risk of hypoglycemia. The risk is dose-dependent and most pronounced during semaglutide titration when insulin doses have not yet been adjusted downward.
Clinical management
Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Ozempic or Insulin Glargine (Lantus).
Monitoring checklist
What to monitor + when to call your prescriber
Routine monitoring
- More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation
Call prescriber urgently if
- shakiness, sweating, confusion, palpitations
- loss of consciousness or seizure
- repeated low glucose readings
Alternatives to discuss
Alternative GLP-1s to discuss with your prescriber
A majorinteraction warrants conversation. Your prescriber may suggest a different GLP-1 if this one isn't right for your full medication profile. We don't prescribe — these are conversation starters.
- Wegovy(semaglutide)View page →
- Zepbound(tirzepatide)View page →
- Mounjaro(tirzepatide)View page →
- Rybelsus(oral semaglutide)View page →
- Saxenda(liraglutide)View page →
Different GLP-1 molecules (semaglutide vs tirzepatide vs liraglutide) have somewhat different interaction profiles. A different class may have less concerning interaction with your other medication.
When to call your doctor
- shakiness, sweating, confusion, palpitations
- loss of consciousness or seizure
- repeated low glucose readings
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Ozempic and Wegovy USPI Warnings and Precautions discuss hypoglycemia risk with concomitant insulin or insulin secretagogues.
Editorial confidence: 10/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
References
FDA Guidance for Industry: Clinical Drug Interaction Studies(2020)
GLP-1 Receptor Agonist Drug Interactions: Comprehensive Review (Diabetes Therapy)(2023)
DailyMed (NIH): FDA Prescribing Information Repository(2024)
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms and Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Common questions
Can I take Insulin Glargine (Lantus) with Ozempic?
High clinical risk — discuss with your prescriber before combining. Insulin dose is typically reduced when starting or escalating semaglutide. All dosing decisions should be made by the prescriber. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Ozempic + Insulin Glargine (Lantus) interaction?
Concomitant use of semaglutide with basal insulin produces additive glucose-lowering effects, materially increasing the risk of hypoglycemia. The risk is dose-dependent and most pronounced during semaglutide titration when insulin doses have not yet been adjusted downward.
What should I monitor when on Ozempic + Insulin Glargine (Lantus)?
More frequent fingerstick or CGM glucose monitoring during initiation and dose escalation; periodic A1c.
When should I call my doctor?
Contact your prescriber if you notice any of: shakiness, sweating, confusion, palpitations; loss of consciousness or seizure; repeated low glucose readings.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.